+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06818435

Registry Study Evaluating Safety and Performance of Meril Myval Transcatheter Aortic Valve Implantation in Adults with Severe Symptomatic Aortic Valve Stenosis

Led by Portuguese Association of Interventional Cardiology · Updated on 2026-01-16

150

Participants Needed

6

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and performance of the Myval THV series device used in Transcatheter Aortic Valve Implantation TAVI procedures for patients with symptomatic severe native aortic valve stenosis. This prospective, single-arm, multi-centre registry aims to gather real-world data on this treatment approach to better understand its use in this condition. Participants will undergo the TAVI procedure using the Myval THV series device. The study is observational and does not involve comparison groups or placebo treatments. The registry will collect data on the procedure and device performance over time, focusing on safety outcomes within 30 days and extending observations up to 12 months. During the study, participants will be monitored through registry procedures and follow-up visits. Researchers will assess safety outcomes at 30 days and measure both safety and performance at 30 days and 12 months after the procedure. Participants will provide informed consent and are expected to comply with all registry requirements, including follow-up evaluations.

CONDITIONS

Brief Title

Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry

Research Team

A

Ana Domingues

J

Joana D Silva, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here